Search
Dr Mariia Nesterkina
Department of Drug Design and Optimization ; Department of Drug Delivery across Biological Barriers . Her research interests are focused on Bioorganic/Medicinal Chemistry as well as Drug Delivery. Her [...] on innovative drug delivery…
Read moreRoman Joeres
the Drug Bioinformatics group as a PhD student. His research focuses on durg-target-interaction prediction using graph neural networks and explainable artificial intelligence (XAI). Predicting drug-tar [...] drug-target-interactions helps…
Read moreCarene Benasolo
machine learning methods. Afterward, she joined the Drugs Bioinformatics group for her first postdoctoral position. She will be working on the DrugSiderAI project to model the functional effects of co [...] degree in Biotechnology and…
Read moreDr Walid A. M. Elgaher
focuses on the application of modern drug design approaches tackling un(der)exploited therapeutic targets and the use of biophysical and computational techniques for drug discovery and optimization.
Read moreDr Alexander Kiefer
research endeavors were centered on the development of anthraquinone-fused enediyne-based antibody-drug conjugates as promising anticancer agents. Upon returning to HIPS in mid-2024 on a DFG Walter Benjamin [...] Groups grant. This enabled…
Read moreAlper Yurtseven
University of Saarland in 2022. Following the master's degree, he started as a PhD student in the Drug Bioinformatics group at Helmholtz Institute for Pharmaceutical Research Saarland. His research focuses
Read moreAmay Ajaykumar Agrawal
Bioengineering from TU Dresden, Germany. Following his Master's degree, he started as a PhD student in Drug Bioinformatics group in November, 2021. His research focuses on using explainable Artificial Intelligence
Read moreSimone Rosinus
product antibiotics, the investigation of pharmacokinetics, and the assessment of synergistic effects of drug combinations. She is also working on the validation of screening tools and the chemical optimization
Read moreDr Angela Sester
Dortmund University under Prof. Dr. Markus Nett, where she mainly investigated myxobacteria for new drug classes. As a postdoc at the TU Dresden with Prof. Dr. Tobias A. M. Gulder, the research focus shifted
Read moreQinyuan Liu
generative models to design novel protein sequences and applies explainable AI (XAI) techniques to Drug-Target Interaction (DTI) models. These efforts aim to identify critical protein residues, enabling
Read more